Products for Research Use Only

Hederacoside C

CAT: 0013-GTR19160530-03Size: 500 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19160530-03Size:500 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
CAS Number
14216-03-6
Product Name Alternative
Kalopanaxsaponin B | Hederacoside C | Hederoside H1
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 100 mg/mL (81.87 mM)
Smiles
[C@@H]1 ([C@@H] (OC[C@@H] ([C@@H]1O) O) O[C@@H]1[C@] ([C@H]2[C@@] ([C@@H]3[C@] ([C@]4 (C (=CC3) [C@H]3[C@@] (CC4) (CCC (C3) (C) C) C (=O) O[C@H]3[C@@H] ([C@H] ([C@@H] ([C@H] (O3) CO[C@H]3[C@@H] ([C@H] ([C@H] (O[C@H]4[C@@H] ([C@@H] ([C@H] ([C@@H] (O4) C) O) O) O) [C@H] (O3) CO) O) O) O) O) O) C) (CC2) C) (CC1) C) (CO) C) O[C@H]1[C@@H] ([C@@H] ([C@H] ([C@@H] (O1) C) O) O) O
Molecular Formula
C59H96O26
Molecular Weight
1221.39
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Olean-12-en-28-oic acid, 3- ((2-O- (6-deoxy-alpha-L-mannopyranosyl) -alpha-L-arabinopyranosyl) oxy) -23-hydroxy-, O-6-deoxy-alpha-L-mannopyranosyl- (1-4) -O-beta-D-glucopyranosyl- (1-6) -beta-D-glucopyranosyl ester, (3beta,4alpha) -

Chemical Information

Hederacoside C

Kalopanaxsaponin B is a triterpenoid saponin with hederagenin as the aglycone part. It has been isolated from the stem bark of Kalopanax pictus. It has a role as an anti-inflammatory agent and a plant metabolite. It is a pentacyclic triterpenoid, a carboxylic ester and a triterpenoid saponin. It is functionally related to a hederagenin.

CAS Number14216-03-6
PubChem CID11491905
IUPAC Name[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
Molecular FormulaC59H96O26
Molecular Weight1221.4
XLogP-2
Topological Polar Surface Area413
Hydrogen Bond Donor Count15
Hydrogen Bond Acceptor Count26
Rotatable Bond Count14
Heavy Atom Count85
Formal Charge0
Complexity2370
SMILES
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@@]45CC[C@@]6(C(=CC[C@H]7[C@]6(CC[C@@H]8[C@@]7(CC[C@@H]([C@@]8(C)CO)O[C@H]9[C@@H]([C@H]([C@H](CO9)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)C)C)[C@@H]4CC(CC5)(C)C)C)O)O)O)CO)O)O)O
InChI
InChI=1S/C59H96O26/c1-24-34(63)38(67)42(71)49(78-24)83-46-29(20-60)80-48(45(74)41(46)70)77-22-30-37(66)40(69)44(73)51(81-30)85-53(75)59-17-15-54(3,4)19-27(59)26-9-10-32-55(5)13-12-33(56(6,23-61)31(55)11-14-58(32,8)57(26,7)16-18-59)82-52-47(36(65)28(62)21-76-52)84-50-43(72)39(68)35(64)25(2)79-50/h9,24-25,27-52,60-74H,10-23H2,1-8H3/t24-,25-,27-,28-,29+,30+,31+,32+,33-,34-,35-,36-,37+,38+,39+,40-,41+,42+,43+,44+,45+,46+,47+,48+,49-,50-,51-,52-,55-,56-,57+,58+,59-/m0/s1
InChIKey
RYHDIBJJJRNDSX-MCGLQMIESA-N
Chemical Structure
2D Structure
2D structure of Hederacoside C
CAS: 14216-03-6
CID: 11491905
Formula: C59H96O26
MW: 1221.4
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight1221.4
XLogP3-2
Hydrogen Bond Donor Count15
Hydrogen Bond Acceptor Count26
Rotatable Bond Count14
Exact Mass1220.61898316
Monoisotopic Mass1220.61898316
Topological Polar Surface Area413 Ų
Heavy Atom Count85
Formal Charge0
Complexity2370
Isotope Atom Count0
Defined Atom Stereocenter Count33
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products